Trussell J, Stewart F, Potts M, Guest F, Ellertson C
Department of Economics, Woodrow Wilson School of Public and International Affairs, Princeton University, NJ 08544.
Am J Public Health. 1993 Aug;83(8):1094-9. doi: 10.2105/ajph.83.8.1094.
In this paper, it is argued that oral contraceptives should be available without prescription. Prescription status entails heavy costs, including the dollar, time, and psychological costs of visiting a physician to obtain a prescription, the financial and human costs of unintended pregnancies that result from the obstacle to access caused by medicalization of oral contraceptives, and administrative costs to the health care system. After a review and evaluation of the reasons for strict medical control of oral contraceptives in the United States, safety concerns anticipated in response to the proposal discussed here are addressed. Also, concerns that prescription status is necessary for efficacious use are evaluated. It is concluded that neither safety nor efficacy considerations justify prescription status for oral contraceptives. Revised package design and patient labeling could allow women to screen themselves for contraindications, to educate themselves about danger signs, and to use oral contraceptives safely and successfully. Several alternatives to providing oral contraceptives by prescription with current package design and labeling and selling them over the counter are suggested; the proposals discussed would make these safe and effective contraceptives easier to obtain and to use.
本文认为,口服避孕药应无需处方即可获取。处方要求带来了高昂成本,包括看医生开处方的金钱、时间和心理成本,口服避孕药因医疗化导致获取障碍而引发意外怀孕的财务和人力成本,以及医疗保健系统的管理成本。在回顾和评估美国对口服避孕药进行严格医疗管控的原因后,针对此处讨论的提议可能引发的安全担忧进行了探讨。此外,还评估了关于有效使用口服避孕药必须有处方的观点。结论是,无论是安全考量还是疗效考量,都不能成为口服避孕药需凭处方获取的理由。修订包装设计和患者标签可以让女性自行筛查禁忌情况,自我了解危险信号,并安全、成功地使用口服避孕药。文中提出了几种替代方案,以取代现行包装设计和标签下凭处方提供口服避孕药并在柜台销售的方式;所讨论的提议将使这些安全有效的避孕药更易于获取和使用。